Lorcaserin Extended-Release Tablets and Sodium zirconium cyclosilicate
Determining the interaction of Lorcaserin Extended-Release Tablets and Sodium zirconium cyclosilicate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: sodium zirconium cyclosilicate
Brand name: Lokelma
Synonyms: Sodium Zirconium Cyclosilicate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Sofosbuvir
- Lorcaserin Extended-Release Tablets-Sofosbuvir and velpatasvir
- Lorcaserin Extended-Release Tablets-Sofosbuvir Tablets
- Lorcaserin Extended-Release Tablets-Sofosbuvir, velpatasvir, and voxilaprevir
- Lorcaserin Extended-Release Tablets-Sojourn
- Lorcaserin Extended-Release Tablets-Sojourn Inhalant
- Sodium zirconium cyclosilicate-Lorcaserin Hydrochloride
- Sodium zirconium cyclosilicate-Lorcaserin Tablets
- Sodium zirconium cyclosilicate-Lorcet
- Sodium zirconium cyclosilicate-Lorcet Plus
- Sodium zirconium cyclosilicate-Lorcet Tablets
- Sodium zirconium cyclosilicate-Lorlatinib